AI-generated summary
The authors studied photobiomodulation (light therapy) in a mouse model of allergic contact dermatitis and in isolated T cells in the laboratory. They report that the treatment reduced the number of T cells and inhibited T cell activation, with TGF-beta signaling implicated as a possible pathway. The study was conducted in mice and cells, not in people.
- Who or what was studied
- C57BL/6 mice with allergic contact dermatitis, and naive T cells isolated for in vitro experiments
- Limits stated in the abstract
- Findings come from mouse and in vitro cell experiments, and the abstract does not report a human sample or the light parameters used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Reactive oxygen species. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.